CRISPR-Cas editing of C. albicans holds promise for overcoming deadly fungal infections
By modifying the CRISPR-Cas genome editing system, Whitehead Institute researchers are now able to manipulate Candida albicans' genome systematically—an approach that could help identify novel targets for therapies against ...